In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality
- PMID: 34606320
- DOI: 10.7326/ACPJ202110190-113
In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality
Abstract
RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021;397:2049-59. 34000257.
Comment on
-
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.Lancet. 2021 May 29;397(10289):2049-2059. doi: 10.1016/S0140-6736(21)00897-7. Epub 2021 May 14. Lancet. 2021. PMID: 34000257 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical